MariMed CEO To Share Cannabis Public vs Private Investing Insight at Kahner Global Cannabis Private Investment Summit
New Green Market Report Marijuana Index includes MariMed Inc.
NEWTON, Mass. and FT. LAUDERDALE, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQB:MRMD) CEO Robert Fireman will be a panelist at the Kahner Global Cannabis Private Investment Summit, in Ft. Lauderdale, Fla., on February 21, 2018, for the Investor Roundtable focusing on “Public vs. Private.” The panel will be moderated by Candice Beaumont, Chief Investment Officer, L Investments. Panelists include:
- Ryan Ansin, Ansin Investments, LLC
- David Traylor, Senior Managing Director, Golden Eagle Partners
- Adam Verner, Managing Partner, Springhouse
- Robert Fireman, CEO, MariMed Inc.
Mr. Fireman will draw on his expertise as both a public and private company in the cannabis industry as he led MariMed’s transition into a public entity while funding, developing and operating some of the nation’s most acclaimed state licensed cannabis cultivation, production, and dispensing facilities in multiple states.
“We have brought together ultra high net worth investors and family offices; private and public companies; cannabis facility operators; consultants; medical, product and marketing experts; fund managers; attorneys and publishers to discuss the critical topics facing the cannabis industry,” said Noa Kahner, Founder and CEO of Kahner Global. “As more states legalize cannabis, more attention is focusing on industry investment and determining where the best opportunities lie. MariMed CEO Bob Fireman brings a long and proven track record in the cannabis industry to our event, so it will be especially interesting for our attendees to tap into his knowledge and expertise, as well as that of his fellow panelists, regarding funding within the industry.”
Conference speakers include JJ McKay, publisher of FreshToast; Kevin McGovern, CEO of McGovern Capital; Ben Way, CEO Rainmakers Inc.; Jordan Tishler MD; Drake Sutton-Shearer, CEO of PRØHBTD Media; Ben Kovler, CEO of GTI; Matthew Ginder, Esq., Greenspoon Marder LLP; Teddy Scott, CEO of PharmaCann and many more. Conference info is available at: https://www.cannabrunch.net/
MariMed is on the New Green Market Report Marijuana Index
MariMed is one of the top 40 publicly traded companies included in Green Market Report’s new Marijuana Index. MariMed is also listed on the U.S. Marijuana Index, (www.marijuanaindex.com) and CannabIndex.
About MariMed Inc.
MariMed is an industry leader in the development and operation of state licensed regulatory compliant cannabis cultivation, production, and dispensary facilities in multiple states across the country. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. MariMed is on the forefront of precision dosed products for the treatment of specific medical conditions. It currently distributes its branded products in select states and is expanding licensing and distribution to numerous additional states encompassing thousands of dispensaries. MariMed Inc., is one of the 17 top-performing public cannabis companies in the U.S. tracked on the U.S. Marijuana Index, (www.marijuanaindex.com). For more info visit www.MarimedAdvisors.com
Jon Levine, CFO, MariMed
Tyler Troup, Circadian Group
+1 (866) 950 8300
Julie Shepherd, Accentuate PR
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8698aad9-7591-462e-b51b-50b15843b543
Released February 20, 2018